Liang Yang

Liang Yang

Auto-generated profile, based on publicly available information

Liang Yang

Department of Radiation Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
ZFZhiyuan Fan
Zhiyuan Fan
YSYuheng Shao
Yuheng Shao
XJXiao Jiang
Xiao Jiang
JZJinglan Zhou
Jinglan Zhou
LYLiang Yang
Liang Yang
WLWentao Liu
Wentao Liu


5 March 2026 in Cell Reports
Verified
Journal Article
Open access
CLChao Li
Chao Li
HZHan Zhao
Han Zhao
JWJingjing Wang
Jingjing Wang
CLChenfei Liu
Chenfei Liu
SHShiqing He
Shiqing He
BDBin Du
Bin Du
Tumor-resident microbiota are identified as a critical modulator in the carcinogenesis and progression of cervical malignancies. However, the mechanisms linking these microbiota to cervical cancer remain poorly understood. In this study, we find that patients with cervical cancer exhibit increased microbiota diversity, characterized by eight distinct bacterial species that distinguish them from control subjects. Intratumoral or intravenous administration of an isolated strain, Gordonia polyisoprenivorans GP-2, derived from tumor-resident microbiota, significantly promotes the growth and metastasis of cervical cancer in mice. Further investigation reveals that GP-2 metabolizes host-derived choline to produce the bacterial metabolite lysophosphatidylcholine (lysoPC). We propose and validate the biosynthetic pathway for lysoPC in strain GP-2 and demonstrate that lysoPC activates the classical tumorigenic genes c-Jun/c-Fos using cervical tumor organoids derived from patients. These findings elucidate the mechanisms underlying microbiota-host crosstalk in cervical cancer and highlight a potential therapeutic target for intervening in tumor-resident bacteria.

7 February 2026 in Communications Biology
Verified
Journal Article
Open access
PDF file
YZYumeng Zhang
Yumeng Zhang
YSYuheng Shao
Yuheng Shao
XLXin Li
Xin Li
DZDongdong Zhou
Dongdong Zhou
JZJinglan Zhou
Jinglan Zhou
LYLiang Yang
Liang Yang
The enzymes acetyl-CoA acetyltransferase (ACATs) are membrane-bound enzymes that play critical roles in the regulation of cellular cholesterol homeostasis in various tissues. Here, we aim to assess the effect of ACAT2 on lipid accumulation in cervical cancer (CC). ACAT2 expression is enhanced in CC and is closely associated with the immune evasion and clinical progression of CC. Knockdown of ACAT2 expression in CC cells inhibits CC growth, improves survival in tumor-bearing C57BL/6 mice, and enhances anti-tumor immune responses by natural killer and CD8+ T cells. Protein expression of sterol regulatory element-binding transcription factor 2 (SREBF2) is elevated in CC and mediates the transcriptional activation of ACAT2. E3 ubiquitin-protein ligase parkin (PRKN) expression is attenuated in CC, which results in a diminished level of ubiquitination of SREBF2 and enhanced stability of SREBF2. PRKN inhibits cholesterol accumulation in CC, activates mitophagy, and ameliorates immune evasion through inhibition of SREBF2/ACAT2. Overexpression of SREBF2 blocks the anti-tumor effects of PRKN in an ACAT2-dependent manner. The present study underscores the pivotal function of ACAT2 in CC progression and delineates its potential as a therapeutic latent strategy. This approach involves the strategic obstruction of the metabolic pathway associated with ACAT2.

13 July 2025 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
DZDongdong Zhou
Dongdong Zhou
YSYuheng Shao
Yuheng Shao
FWFuying Wan
Fuying Wan
JCJiayi Chen
Jiayi Chen
YZYumeng Zhang
Yumeng Zhang
LYLiang Yang
Liang Yang
Purpose: Based on the combination mode of internal and external radiotherapy for cervical cancer, this study aimed to investigate an accurate transformer‐based deformable image registration (DIR) method for cumulative dose assessment. Methods and Materials: According to a retrospective analysis conducted on 180 patients with cervical cancer who underwent intracavitary brachytherapy (ICBT) and external beam radiation therapy (EBRT), this study proposed a mix‐transformer structure‐based deformable image registration (MTDIR) network for registering CT scans of ICBT and EBRT, followed by dose accumulation and assessment. The mean dice similarity coefficient (DSC) and Hausdorff distance (HD) of the rectum and bladder were computed to compare the performance of MTDIR with that of the state‐of‐the‐art VoxelMorph method and the DIR method provided by velocity. Additionally, the cumulative dose of the bladder and rectum from four methods was calculated: direct DVH parameter addition (DA), DIR‐based dose addition provided by Velocity (VA), VoxelMorph‐based dose addition (VoA), and MTDIR‐based dose addition (MA). Results: The mean DSC values of MTDIR, VoxelMorph, and Velocity for the bladder were 0.78, 0.75, and 0.72 for the registration between CT scans of EBRT and the last ICBT, respectively. The mean DSC values of the rectum were also equal to 0.58, 0.56, and 0.52. The mean HDmean values of MTDIR, VoxelMorph, and Velocity for the bladder were 4.81, 5.16, and 5.43, and the mean HDmean values of the rectum were 5.41, 5.81, and 6.93, respectively. For the registration between CT scans of ICBT, the mean DSC values of MTDIR, VoxelMorph, and Velocity for the bladder were obtained 0.82, 0.80, and 0.77, and the mean DSC values for the rectum were equal to 0.70, 0.68, and 0.63, respectively. The mean HDmean values of MTDIR, VoxelMorph, and Velocity for the bladder were 4.22, 4.58, and 4.79, and the mean HDmean values of the rectum were obtained 4.86, 5.17, and 5.64, respectively. The results generally suggested that MTDIR outperformed VoxelMorph and Velocity. Conclusions: The study findings demonstrated that the model developed based on parameters obtained from the proposed method exhibited higher registration accuracy.

18 June 2026 in Translational Oncology
Verified
Journal Article
Open access
JZJing Zhao
Jing Zhao
XWXintao Wang
Xintao Wang
TLTiankang Li
Tiankang Li
JCJie Chen
Jie Chen
HZHaiyan Zhu
Haiyan Zhu
YLYingchao Liang
Yingchao Liang
Ovarian cancer (OVCA) has the highest mortality rate among all gynecological malignancies. Epidermal growth factor receptor (EGFR) is commonly overexpressed in epithelial OVCA (30-98%) and is significantly positively correlated with poor patient prognosis. However, therapeutic drugs targeting EGFR have not shown promising results, indicating the existence of other potential mechanisms. G-protein-coupled receptor (GPCR) families were reported to crosstalk with EGFR, jointly affecting the activation of downstream signaling pathway networks. G protein-coupled receptor 107 (GPR107), a novel orphan GPCR, is overexpressed in tumors and is involved in cancer progression. Little is known about the role of GPR107 in OVCA progression. In this study, the underlying mechanism of GPR107-EGFR crosstalk and its critical function in OVCA progression were investigated. GPR107, which was highly expressed in OVCA and was associated with advanced clinical stages, could interact with EGFR on the cell membrane and promoted the invasion, migration, and epithelial mesenchymal transition (EMT) of OVCA. Mechanistically, GPR107-EGFR crosstalk promoted EGFR phosphorylation and downstream PI3K/AKT/NF-κB activation, resulting in autocrine IL-6 secretion, which facilitated OVCA metastasis both in vitro and in vivo. Monoclonal antibodies targeting IL-6 could inhibit OVCA metastasis induced by GPR107. In conclusion, our study highlights the importance of GPR107-EGFR crosstalk in OVCA metastasis by clarifying the function and molecular mechanism of GPR107-EGFR crosstalk, and provides a novel direction for developing new treatment strategies for OVCA.